Back to News
August 28, 2026
BiotechExec Places Hal Beckham as Chief Financial Officer of Reselute Medical
AUGUST 28, 2026
Congratulations to Hal Beckham on his placement as Chief Financial Officer of Reselute Medical.
Hal brings a medical technology CFO's track record — orthopedic device finance, growth-stage capital and the path from development to commercialization.
Reselute Medical is developing therapeutic implants that combine definitive fracture fixation with sustained, local antibiotic delivery.
3 weeks from client outreach to placement.
Placement by BiotechExec: Matched and placed from the Ignite Network.
